Skip to main content

Abivax S.A.

ABVX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001956827

No open-market purchases or sales by Abivax S.A. insiders were filed in the last 90 days; 318 institutions reported holding it in 13F filings for Q3 2026, worth $5.64B in total; no superinvestor holds it.

Other share classesAAVXF

Key figures

Market capADS ratio not in SEC data
–
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +15 vs. previous quarter
318
13F valueReported value at the end of Q3 2026
$5.64B
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in EUR.

Revenue, FY2025
EUR 4.57M
−63.3% year over year
Net income, FY2025
EUR -336.1M
No comparable prior period
Free cash flow, FY2025
EUR -161.3M
No comparable prior period

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: EUR 336.1M (7354.5% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
4.11M
Shares sold short
Change
−3.14M
−43.3% vs. previous
Days to cover
4.63
At average daily volume

Superinvestors holding ABVX, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding ABVX at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Abivax S.A. insiders from Form 4, newest first.

No open-market purchases or sales by Abivax S.A. insiders are on file.

Top 10 13F holders, Q3 2026

See all 318 holders

The largest institutional positions in Abivax S.A. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding ABVX in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Helikon Investments Ltd4,222,896$418.2M11.88%+1,435,765+51.5%Added
Darwin Global Management, Ltd.4,021,583$398.2M9.98%+400,000+11.0%Added
Vestal Point Capital, LP3,960,000$392.1M10.13%+1,610,557+68.6%Added
TCG Crossover Management, LLC3,663,038$362.7M10.25%−2,344,796−39.0%Reduced
Janus Henderson Group PLC2,147,116$212.6M0.09%+2,147,116New
ADAR1 Capital Management, LLC2,050,822$203.1M8.71%+246,119+13.6%Added
Westfield Capital Management Co LP1,651,819$163.6M0.54%+341,994+26.1%Added
Caligan Partners LP1,557,924$154.3M9.44%00.0%Unchanged
Morgan Stanley1,437,880$142.4M0.01%+5,695+0.4%Added
Citadel Advisors LLC1,308,467$129.6M0.07%−129,885−9.0%Reduced

Holders of 5% or more of ABVX

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Abivax S.A..

Largest holders of ABVX from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Invus Global Management, LLC13G/A6.00%4.83M shares+1.00 ppfrom 5.00%Apr 11, 20253 filingsAug 13, 2026SEC